13F Pro13F Pro

Prostatis Group LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1649186
Institutional-grade research for retail investors

Sector Allocation

  • Other74.4%$344.6M
  • Technology10.3%$47.9M
  • Financials8.0%$36.9M
  • Energy1.7%$7.8M
  • Consumer Discretionary1.5%$7.0M
  • Healthcare1.4%$6.2M
  • Industrials1.1%$5.3M
  • Consumer Staples0.7%$3.0M
  • Utilities0.5%$2.1M
  • Communication Services0.4%$1.7M

AUM History

13fpro.ai/research/fund/prostatis-group-llc-1649186

Conviction and streaks

Stable · top 10 = 43.1%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

Largest positions — Q3 2026

  • THOR
    $75.9M
  • AMPLIFY
    $21.0M
  • QQQQQQ
    $14.9M
  • VANGUARD
    $14.4M
  • VANGUARD
    $14.0M
  • SPDR
    $14.0M
  • ISHARES
    $13.7M
  • VANGUARD
    $12.8M
  • ISHARES
    $9.9M
  • VANGUARD
    $9.1M
  • ETF
    $8.0M
  • AAPLAAPL
    $7.8M
  • IVZIVZ
    $7.0M
  • IVZIVZ
    $6.9M
  • SCHWAB
    $6.9M
  • INVESCO
    $6.4M
  • SPDR
    $6.2M
  • MSFTMSFT
    $5.8M
  • FRANKLIN
    $5.8M
  • NVDANVDA
    $5.4M

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/prostatis-group-llc-1649186

Prostatis Group LLC 13F holdings — Q3 2026

$463.3M portfolio (+7.9% QoQ) · 200 holdings · Q3 2026 13F · top 10 are 43% of the stock portfolio

  • 1

    THOR FINL TECHNOLOGIES TR - INDEX ROTATION

    $75.9M

    16.4% of stocks

    +8%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 2

    AMPLIFY ETF TR - CWP ENHANCED DIV

    $21.0M

    4.5% of stocks

    -1%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • -10%This quarter-5.1%Since filed7+ qtrsHeld
    AIQuality—Est. buyEstimated buy price is Pro: unlock with a free trialTrimmed 5 qtrs in a row
  • 4

    VANGUARD INDEX FDS - MRNGSTR GRWT ETF

    $14.4M

    3.1% of stocks

    +15%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 5

    VANGUARD INDEX FDS - MRNGSTR MID CAP

    $14.0M

    3.0% of stocks

    NewThis quarter—Since filedNew this quarterHeld
    AIQuality—Est. buy—
  • 6

    SPDR SERIES TRUST - ST STR NYSE TECH

    $14.0M

    3.0% of stocks

    +39%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 7

    ISHARES TR - EXPND TEC SC ETF

    $13.7M

    3.0% of stocks

    +15%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 8

    VANGUARD INDEX FDS - MRNGSTR VAL ETF

    $12.8M

    2.8% of stocks

    +184%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 9

    ISHARES TR - US BR DEL SE ETF

    $9.9M

    2.1% of stocks

    +28%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 10

    VANGUARD INDEX FDS - MRNGSTR SML CAP

    $9.1M

    2.0% of stocks

    NewThis quarter—Since filedNew this quarterHeld
    AIQuality—Est. buy—

All holdings — Prostatis Group LLC (Q3 2026)

200 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
— ETF OPPORTUNITIES TRUST - AI FDS HIGH CONVetf/fund$8.0MNew
AAPL$AAPLApple Inc.$7.8M+7%
IVZ$IVZInvesco Ltd.$7.0M+0.8%
IVZ$IVZInvesco Ltd.$6.9M+6%
— SCHWAB STRATEGIC TR - US LCAP GR ETFetf/fund$6.9M+415%
— INVESCO EXCHANGE TRADED FD T - LARG CAP GRO ETFetf/fund$6.4M-26%
— SPDR SERIES TRUST - ST STR P500ETFetf/fund$6.2M+16%
MSFT$MSFTMICROSOFT CORP$5.8M-2%
— FRANKLIN TEMPLETON ETF TR - INTL COR DIV TILetf/fund$5.8M+16%
NVDA$NVDANVIDIA CORP$5.4M+10%
GLD$GLDSPDR GOLD TRUSTetf/fund$5.4M-25%
— FIRST TR EXCH TRADED FD III - LNG/SHT EQUITY$5.3M+8%
IVZ$IVZInvesco Ltd.$5.2M-2%
— ISHARES INC - MSCI GERMANY ETFetf/fund$5.1M+0.9%
— ISHARES INC - MSCI ITALY ETFetf/fund$5.1M+0.7%

What changed in Q3 2026

Against the previous quarter's 13F: 36 new, 103 added to, 57 trimmed, 22 sold out. Share-count changes; largest moves by dollar size first.

New positions (36)

  • VANGUARD INDEX FDS - MRNGSTR MID CAP$14.0M

    first bought this quarter

  • VANGUARD INDEX FDS - MRNGSTR SML CAP$9.1M

    first bought this quarter

  • ETF OPPORTUNITIES TRUST - AI FDS HIGH CONV$8.0M

    first bought this quarter

  • ISHARES TR - MSCI INDIA ETF$4.1M

    first bought this quarter

  • ISHARES INC - MSCI CDA ETF$4.1M

    first bought this quarter

  • SCHWAB STRATEGIC TR - US DIVIDEND EQ$3.8M

    first bought this quarter

+30 more in the Excel export

Added to (103)

  • VANGUARD INDEX FDS - MRNGSTR VAL ETF+184%

    now $12.8M

  • THOR FINL TECHNOLOGIES TR - INDEX ROTATION+8%

    now $75.9M

  • SCHWAB STRATEGIC TR - US LCAP GR ETF+415%

    now $6.9M

  • SPDR SERIES TRUST - ST STR NYSE TECH+39%

    now $14.0M

  • ISHARES INC - MSCI STH KOR ETF+476%

    now $4.7M

  • ISHARES TR - US BR DEL SE ETF+28%

    now $9.9M

+97 more in the Excel export

Trimmed (57)

  • EXCHANGE LISTED FDS TR - QRAFT AI US MMTM-87%

    now $1.5M

  • ISHARES TR - U.S. TECH ETF-92%

    now $810K

  • SPDR SERIES TRUST - ST STR BLO 1 ETF-61%

    now $3.3M

  • ISHARES INC - MSCI FRANCE ETF-85%

    now $695K

  • INVESCO EXCHANGE TRADED FD T - LARG CAP GRO ETF-26%

    now $6.4M

  • ISHARES TR - CORE S&P500 ETF-43%

    now $2.9M

+51 more in the Excel export

Sold out (22)

  • EXCHANGE LISTED FDS TR - QRAFT AI ENHCDwas $8.3M
  • ISHARES TR - SP SMCP600VL ETFwas $2.2M
  • ISHARES TR - SELECT US REITwas $527K
  • MCK$MCKMCKESSON CORPwas $369K
  • IBM$IBMINTERNATIONAL BUSINESS MACHINES CORPwas $302K
  • BMY$BMYBRISTOL MYERS SQUIBB COwas $296K

+16 more in the Excel export

Firm AUM (Form ADV): $605.4M as of 2025-12-31 · SEC IAPD

Holdings by quarter

Every 13F Prostatis Group LLC has filed, 27 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Prostatis Group?

Q3 2026 13F filed with the SEC on Nov 13, 2026. Prices are closing prices as of Nov 19, 2026.

Average quality of Prostatis Group's top 20 holdings: 74/100 (our AI quality score, weighted by position size; 15 of the 20 are scored)

Top 10 since filing

-5.0%

Value-weighted move of the 10 largest stock positions

Turnover

23%

Last quarter; 53% over the last 4

Top 10 weight

43%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

86%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Prostatis Group LLC disclosed 200 positions worth $463.3M in its Form 13F-HR for Q3 2026. During the quarter the fund opened 36 new positions and exited 22. The portfolio is most concentrated in Other (74.4% of disclosed assets). All figures are sourced directly from Prostatis Group LLC’s Form 13F-HR filing with the SEC under CIK 1649186.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Prostatis Group LLC

13F Pro is an AI hedge fund tracker and stock research platform. For Prostatis Group LLC (SEC CIK: 1649186), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Prostatis Group LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.